Listening to the webcast, there are a number of significant results expected second half of this year.
For us long term holders desperados (hanging on and treating BOTA like a casino stock), the Vapendavir trial results will determine whether we see a partnership coming (and an SP boost) and will pretty much be the last straw in any medium term success - failing success here, I reckon the cash burn will finally catch up with Biota as they advance their other products.
BTA Price at posting:
57.0¢ Sentiment: Hold Disclosure: Held
